Gender
|
Female
|
31 (48.5%)
|
---|
|
Male
|
33 (51.5%)
|
|
Unknown
|
1
|
Age
|
Mean
|
42.84 years (range from 25 to 71)
|
|
Median
|
42 years
|
Countries of origin
|
West Africa
|
29 (63%)
|
|
Ghana
|
8
|
|
Ivory Coast
|
7
|
|
Cape Verde Islands
|
5
|
|
Guinea-Bissau
|
3
|
|
Guinea
|
2
|
|
Senegal
|
1
|
|
Liberia
|
1
|
|
Nigeria
|
1
|
|
Burkina-Faso
|
1
|
|
Europe
|
11 (24%)
|
|
Belgium
|
6
|
|
Portugal
|
5
|
|
Central and Southern Africa
|
4 (8.5%)
|
|
Democratic Republic Congo
|
3
|
|
South-Africa
|
1
|
|
Asia: Nepal
|
2 (4%)
|
|
Not documented
|
19
|
Transmission
|
Heterosexual
|
37 (86%)
|
|
Homosexual (MSM)
|
2 (4.5%)
|
|
Intra-venous drug use
|
2 (4.5%)
|
|
Transfusion
|
2 (4.5%)
|
|
Not documented
|
22
|
Year of infection
|
Between 2002 and 2006
|
10 (33%)
|
|
Between 1997 and 2001
|
7 (23%)
|
|
Before 1997
|
13 (43%)
|
|
Not documented
|
22
|
ARV use
|
Treated
|
20 (31%)
|
|
Exposed to NRTIs only
|
5
|
|
Exposed to NRTIs and PIs
|
15
|
|
Treated at the end of 2006
|
15
|
|
Never been treated
|
45 (69%)
|
Subtype
|
A
|
25 (83%)
|
|
B
|
5 (17%)
|
|
Not documented
|
35
|
- The percentages were calculated for patients with available data (collected until 2006-12-31). ARV: antiretroviral therapy